What’s in a name?
“As we continue to see progress in ocular surface therapeutics, we need to continue to evolve our vocabulary surrounding ocular surface disease. I challenge you to start differentiating your ‘dry eye’ patients as you see them in clinic,” said Cornea Editor Julie Schallhorn, MD. Read her introduction to the Cornea section for more details.
